JP2020073529A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020073529A5 JP2020073529A5 JP2019234042A JP2019234042A JP2020073529A5 JP 2020073529 A5 JP2020073529 A5 JP 2020073529A5 JP 2019234042 A JP2019234042 A JP 2019234042A JP 2019234042 A JP2019234042 A JP 2019234042A JP 2020073529 A5 JP2020073529 A5 JP 2020073529A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pediatric patient
- dexmedetomidine
- composition according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- HRLIOXLXPOHXTA-NSHDSACASA-N dexmedetomidine Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=CN=C[N]1 HRLIOXLXPOHXTA-NSHDSACASA-N 0.000 claims 8
- 229960004253 dexmedetomidine Drugs 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 238000012423 maintenance Methods 0.000 claims 5
- 206010039897 Sedation Diseases 0.000 claims 4
- 238000001802 infusion Methods 0.000 claims 4
- 238000001990 intravenous administration Methods 0.000 claims 4
- 230000036280 sedation Effects 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 206010002091 Anaesthesia Diseases 0.000 claims 1
- 230000037005 anaesthesia Effects 0.000 claims 1
- 238000005399 mechanical ventilation Methods 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 238000002627 tracheal intubation Methods 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021163378A JP2022008828A (ja) | 2011-10-14 | 2021-10-04 | デクスメデトミジンを用いて小児患者を治療する方法 |
| JP2023181585A JP2023179764A (ja) | 2011-10-14 | 2023-10-23 | デクスメデトミジンを用いて小児患者を治療する方法 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161547626P | 2011-10-14 | 2011-10-14 | |
| US61/547,626 | 2011-10-14 | ||
| US13/343,693 | 2012-01-04 | ||
| US13/343,693 US20130096170A1 (en) | 2011-10-14 | 2012-01-04 | Methods of treating pediatric patients using dexmedetomidine |
| US13/471,403 US8324260B1 (en) | 2011-10-14 | 2012-05-14 | Methods of treating pediatric patients using dexmedetomidine |
| US13/471,403 | 2012-05-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017189989A Division JP6640164B2 (ja) | 2011-10-14 | 2017-09-29 | デクスメデトミジンを用いて小児患者を治療する方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021163378A Division JP2022008828A (ja) | 2011-10-14 | 2021-10-04 | デクスメデトミジンを用いて小児患者を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020073529A JP2020073529A (ja) | 2020-05-14 |
| JP2020073529A5 true JP2020073529A5 (enExample) | 2020-08-27 |
Family
ID=47226666
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014535738A Active JP6270727B2 (ja) | 2011-10-14 | 2012-09-27 | デクスメデトミジンを用いて小児患者を治療する方法 |
| JP2017189989A Active JP6640164B2 (ja) | 2011-10-14 | 2017-09-29 | デクスメデトミジンを用いて小児患者を治療する方法 |
| JP2019234042A Pending JP2020073529A (ja) | 2011-10-14 | 2019-12-25 | デクスメデトミジンを用いて小児患者を治療する方法 |
| JP2021163378A Withdrawn JP2022008828A (ja) | 2011-10-14 | 2021-10-04 | デクスメデトミジンを用いて小児患者を治療する方法 |
| JP2023181585A Pending JP2023179764A (ja) | 2011-10-14 | 2023-10-23 | デクスメデトミジンを用いて小児患者を治療する方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014535738A Active JP6270727B2 (ja) | 2011-10-14 | 2012-09-27 | デクスメデトミジンを用いて小児患者を治療する方法 |
| JP2017189989A Active JP6640164B2 (ja) | 2011-10-14 | 2017-09-29 | デクスメデトミジンを用いて小児患者を治療する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021163378A Withdrawn JP2022008828A (ja) | 2011-10-14 | 2021-10-04 | デクスメデトミジンを用いて小児患者を治療する方法 |
| JP2023181585A Pending JP2023179764A (ja) | 2011-10-14 | 2023-10-23 | デクスメデトミジンを用いて小児患者を治療する方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (8) | US20130096170A1 (enExample) |
| EP (2) | EP2766014B1 (enExample) |
| JP (5) | JP6270727B2 (enExample) |
| KR (3) | KR20200019791A (enExample) |
| CN (2) | CN109700806A (enExample) |
| AU (3) | AU2012321246C1 (enExample) |
| BR (1) | BR112014008983A2 (enExample) |
| CA (2) | CA2851780C (enExample) |
| CY (1) | CY1121041T1 (enExample) |
| DK (1) | DK2766014T3 (enExample) |
| ES (1) | ES2685814T3 (enExample) |
| HK (1) | HK1200333A1 (enExample) |
| HR (1) | HRP20181378T1 (enExample) |
| HU (1) | HUE039671T2 (enExample) |
| IL (2) | IL232070A0 (enExample) |
| IN (1) | IN2014KN00996A (enExample) |
| LT (1) | LT2766014T (enExample) |
| MX (1) | MX362626B (enExample) |
| PL (1) | PL2766014T3 (enExample) |
| PT (1) | PT2766014T (enExample) |
| RS (1) | RS57660B1 (enExample) |
| SI (1) | SI2766014T1 (enExample) |
| WO (1) | WO2013055528A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
| US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
| KR20180095732A (ko) * | 2013-10-07 | 2018-08-27 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물 |
| EP3054932B1 (en) | 2013-10-07 | 2020-12-09 | Teikoku Pharma USA, Inc. | Dexmedetomidine transdermal delivery devices and methods for using the same |
| TWI629061B (zh) * | 2013-10-07 | 2018-07-11 | 美商帝國製藥美國股份有限公司 | 包含右美托嘧啶（ｄｅｘｍｅｄｅｔｏｍｉｄｉｎｅ）經皮組成物之疼痛處理用方法及組成物 |
| CN106456561B (zh) | 2013-10-07 | 2020-02-28 | 帝国制药美国公司 | 使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物 |
| US11017330B2 (en) * | 2014-05-20 | 2021-05-25 | Elasticsearch B.V. | Method and system for analysing data |
| WO2016025989A1 (en) | 2014-08-18 | 2016-02-25 | Epat Pty Ltd | A pain assessment method and system |
| CN104784174A (zh) * | 2015-03-06 | 2015-07-22 | 北京大学第一医院 | 右美托咪定的药物新用途 |
| US9717796B1 (en) * | 2016-04-20 | 2017-08-01 | Slypharma, Llc | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
| BR112019006955A2 (pt) * | 2016-10-31 | 2019-07-02 | Teikoku Pharma Usa Inc | métodos de controle da dor usando dispositivos de distribuição transdérmica de dexmedetomidina |
| CN106539778A (zh) * | 2016-12-08 | 2017-03-29 | 武汉大学 | 一种小儿麻醉术前含服口腔泡腾片及其制备方法 |
| SG10202107367SA (en) | 2016-12-31 | 2021-08-30 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| US11783046B2 (en) | 2017-04-26 | 2023-10-10 | Elasticsearch B.V. | Anomaly and causation detection in computing environments |
| US11621969B2 (en) | 2017-04-26 | 2023-04-04 | Elasticsearch B.V. | Clustering and outlier detection in anomaly and causation detection for computing environments |
| CN108042533B (zh) * | 2017-12-25 | 2020-11-13 | 苏州格兰科医药科技有限公司 | 右美托米定在制备用于预防和/或抑制创伤性脑损伤后的神经元死亡的药物组合物中的用途 |
| EP3813828A4 (en) * | 2018-06-27 | 2022-03-30 | Bioxcel Therapeutics, Inc. | METHOD OF TREATMENT OF AGITATION WITH DEXMEDETOMIDIN HYDROCHLORIDE |
| BR112020026672A2 (pt) | 2018-06-27 | 2021-03-30 | Bioxcel Therapeutics, Inc. | Formulações de filme contendo dexmedetomidina e métodos para produzi-las |
| CA3111793A1 (en) * | 2018-09-12 | 2020-03-19 | Hough Ear Institute | Methods for treating hearing loss incident to cochlear implant surgery |
| TWI755629B (zh) * | 2018-09-13 | 2022-02-21 | 台灣微脂體股份有限公司 | 含鎮靜藥物之緩釋藥物組合物及其用途 |
| US20220051802A1 (en) * | 2018-12-13 | 2022-02-17 | Dignity Health | System and method for detection and monitoring of over sedation to prevent harm to patients |
| US10817669B2 (en) | 2019-01-14 | 2020-10-27 | International Business Machines Corporation | Automatic classification of adverse event text fragments |
| CN109793709A (zh) * | 2019-02-22 | 2019-05-24 | 青岛农业大学 | 一种斑海豹用复方注射剂及其制备方法 |
| US11000488B2 (en) * | 2019-03-22 | 2021-05-11 | Syntrix Biosystems Inc. | Treating pain using desmetramadol |
| CA3145388A1 (en) * | 2019-07-19 | 2021-01-28 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
| US20230165520A1 (en) * | 2020-04-17 | 2023-06-01 | Bioventures, Llc | Methods and systems for predicting the effect of inhaled and infused anesthetics |
| KR102815903B1 (ko) | 2021-12-21 | 2025-05-30 | 충남대학교산학협력단 | 감염 환자에서 반코마이신 최적 용량을 결정하는 방법 |
| EP4386768A1 (en) * | 2022-12-13 | 2024-06-19 | Koninklijke Philips N.V. | Active sleep apnea case finding and scheduling system and method of operation thereof |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
| WO2025176701A1 (en) * | 2024-02-19 | 2025-08-28 | Rigshospitalet | Novel pediatric composition of nasal dexmedetomidine |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4407957A (en) | 1981-03-13 | 1983-10-04 | Damon Corporation | Reversible microencapsulation of a core material |
| JPS6058890A (ja) | 1983-09-13 | 1985-04-05 | Mizusawa Ind Chem Ltd | 感熱記録紙用填剤 |
| FI844786A0 (fi) | 1984-12-04 | 1984-12-04 | Farmos Oy | Terapeutiskt utnyttjbar foerening. |
| GB2206880B (en) | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
| US5344840A (en) | 1988-02-29 | 1994-09-06 | Orion-Yhtyma Oy | 4-substituted imidazole derivatives useful in perioperative care |
| US5217718A (en) | 1989-08-18 | 1993-06-08 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
| US5124157A (en) | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
| FI894911A0 (fi) | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
| US5304569A (en) | 1989-11-13 | 1994-04-19 | Orion-Yhtyma Oy | Compositions and their use in lowering intraocular pressure |
| ATE156344T1 (de) | 1991-04-25 | 1997-08-15 | Univ Brown Res Found | Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| PT679088E (pt) | 1992-09-29 | 2002-12-31 | Inhale Therapeutic Syst | Administracao pulmonar de fragmentos activos de hormona paratiroide |
| GB2281206A (en) | 1993-08-25 | 1995-03-01 | Orion Yhtymae Oy | Use of dexmedetomidine |
| FR2718357B1 (fr) | 1994-04-06 | 1997-10-03 | Defarges Alain Moreau | Perfectionnements apportés à un dispositif d'injection par jet sans aiguille. |
| DK0774963T3 (da) | 1994-08-08 | 2001-01-29 | Debiopharm Sa | Farmaceutisk stabilt oxaliplatin-præparat |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| US5654007A (en) | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
| DE19758564A1 (de) | 1997-11-11 | 1999-08-26 | Gruenenthal Gmbh | Formulierung einer Kombination aus Morphin und einem alpha¶2¶-adrenergem Agonisten und deren Verwendung |
| US6716867B1 (en) * | 1998-04-01 | 2004-04-06 | Orion Corporation | Use of dexmedetomidine for ICU sedation |
| AR015744A1 (es) * | 1998-04-01 | 2001-05-16 | Orion Corp | Uso de dexmedetomidina para sedacion en terapia intensiva |
| PE20001396A1 (es) | 1999-01-18 | 2000-12-23 | Gruenenthal Chemie | Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista |
| GB9913677D0 (en) | 1999-06-11 | 1999-08-11 | Imperial College | Formulation |
| US6806291B1 (en) | 2003-10-09 | 2004-10-19 | The Foundation For The Lsu Health Sciences Center | Analgesic compounds, their synthesis and pharmaceutical compositions containing them |
| US20080308444A1 (en) | 2007-06-13 | 2008-12-18 | Baxter International Inc. | Packaging system and method of alerting a practitioner |
| US20100197694A1 (en) | 2008-08-01 | 2010-08-05 | Gerald Horn | Compositions and methods for treatment of diseases and conditions with increased vascular permeability |
| EP2165706A1 (en) | 2008-09-18 | 2010-03-24 | BioAlliance Pharma | Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers. |
| US8100890B2 (en) * | 2008-10-15 | 2012-01-24 | Bioquiddity, Inc. | Special purpose fluid dispenser with pre-filled reservoir |
| US7896843B2 (en) * | 2008-10-15 | 2011-03-01 | Bioquiddity, Inc. | Special purpose fluid dispenser |
| JP5536661B2 (ja) | 2008-10-30 | 2014-07-02 | 国立大学法人 岡山大学 | 局所麻酔用組成物 |
| KR101859486B1 (ko) | 2009-05-15 | 2018-06-28 | 레크로파마, 인코포레이티드 | 설하용 덱스메데토미딘 조성물과 그의 사용 방법 |
| US8410140B2 (en) | 2009-06-01 | 2013-04-02 | The Regents Of The University Of Michigan | Anesthetic methods and compositions |
| US20110152271A1 (en) | 2009-12-17 | 2011-06-23 | Gerald Horn | Compositions and methods for ophthalmic delivery of nasal decongestants |
| FR2959414B1 (fr) | 2010-04-30 | 2016-01-08 | Luc Quintin | Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire |
| US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
| US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
-
2012
- 2012-01-04 US US13/343,693 patent/US20130096170A1/en not_active Abandoned
- 2012-05-14 US US13/471,403 patent/US8324260B1/en active Active
- 2012-09-27 SI SI201231349T patent/SI2766014T1/sl unknown
- 2012-09-27 EP EP12840033.0A patent/EP2766014B1/en not_active Revoked
- 2012-09-27 CA CA2851780A patent/CA2851780C/en not_active Expired - Fee Related
- 2012-09-27 HR HRP20181378TT patent/HRP20181378T1/hr unknown
- 2012-09-27 MX MX2014004548A patent/MX362626B/es active IP Right Grant
- 2012-09-27 EP EP18181747.9A patent/EP3446691A1/en not_active Withdrawn
- 2012-09-27 IN IN996KON2014 patent/IN2014KN00996A/en unknown
- 2012-09-27 LT LTEP12840033.0T patent/LT2766014T/lt unknown
- 2012-09-27 KR KR1020207004550A patent/KR20200019791A/ko not_active Ceased
- 2012-09-27 HK HK15100803.0A patent/HK1200333A1/xx unknown
- 2012-09-27 CN CN201811538616.9A patent/CN109700806A/zh active Pending
- 2012-09-27 ES ES12840033.0T patent/ES2685814T3/es active Active
- 2012-09-27 BR BR112014008983A patent/BR112014008983A2/pt not_active Application Discontinuation
- 2012-09-27 HU HUE12840033A patent/HUE039671T2/hu unknown
- 2012-09-27 PL PL12840033T patent/PL2766014T3/pl unknown
- 2012-09-27 CN CN201280058634.1A patent/CN103957906A/zh active Pending
- 2012-09-27 JP JP2014535738A patent/JP6270727B2/ja active Active
- 2012-09-27 WO PCT/US2012/057652 patent/WO2013055528A1/en not_active Ceased
- 2012-09-27 CA CA2978258A patent/CA2978258A1/en not_active Abandoned
- 2012-09-27 PT PT12840033T patent/PT2766014T/pt unknown
- 2012-09-27 KR KR1020197007143A patent/KR20190029775A/ko not_active Ceased
- 2012-09-27 DK DK12840033.0T patent/DK2766014T3/en active
- 2012-09-27 RS RS20181048A patent/RS57660B1/sr unknown
- 2012-09-27 AU AU2012321246A patent/AU2012321246C1/en not_active Ceased
- 2012-09-27 KR KR1020147012837A patent/KR20140094539A/ko not_active Ceased
- 2012-12-24 US US13/726,479 patent/US8507542B2/en active Active
- 2012-12-24 US US13/726,496 patent/US9314449B2/en active Active
-
2013
- 2013-08-09 US US13/963,885 patent/US20140005243A1/en not_active Abandoned
-
2014
- 2014-04-10 IL IL232070A patent/IL232070A0/en unknown
-
2015
- 2015-11-16 US US14/942,880 patent/US20160067220A1/en not_active Abandoned
-
2017
- 2017-01-09 IL IL249991A patent/IL249991A0/en unknown
- 2017-07-20 AU AU2017206211A patent/AU2017206211B2/en not_active Ceased
- 2017-09-29 JP JP2017189989A patent/JP6640164B2/ja active Active
-
2018
- 2018-09-04 CY CY181100916T patent/CY1121041T1/el unknown
-
2019
- 2019-05-21 US US16/418,754 patent/US20190269657A1/en not_active Abandoned
- 2019-05-21 AU AU2019203564A patent/AU2019203564A1/en not_active Abandoned
- 2019-12-25 JP JP2019234042A patent/JP2020073529A/ja active Pending
-
2020
- 2020-11-11 US US17/095,391 patent/US20210137891A1/en not_active Abandoned
-
2021
- 2021-10-04 JP JP2021163378A patent/JP2022008828A/ja not_active Withdrawn
-
2023
- 2023-10-23 JP JP2023181585A patent/JP2023179764A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020073529A5 (enExample) | ||
| JP2020033360A5 (enExample) | ||
| JP2023179764A5 (enExample) | ||
| JP6257326B2 (ja) | 神経因性疼痛におけるマロノニトリルアミドの使用 | |
| BR112022016100A2 (pt) | Composição farmacêutica compreendendo microgrânulos de liberação sustentada incluindo análogo de glp-1 ou sal farmaceuticamente aceitável do mesmo | |
| RU2018110647A (ru) | Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний | |
| JP2014528474A5 (enExample) | ||
| JP2018513107A5 (enExample) | ||
| JP2016074740A5 (enExample) | ||
| JP2020504128A5 (enExample) | ||
| JPWO2019107530A1 (ja) | 炎症性腸疾患の治療薬 | |
| JP2014520886A5 (enExample) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2017501140A5 (enExample) | ||
| JP2018504984A5 (enExample) | ||
| JP2017533972A5 (enExample) | ||
| JP2017105861A5 (enExample) | ||
| JP2017105862A5 (enExample) | ||
| JP2017507145A5 (enExample) | ||
| JP2020536121A5 (enExample) | ||
| WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
| Gallesio et al. | Conservative treatment with plasma rich in growth factors-Endoret for osteoradionecrosis | |
| JOP20190019A1 (ar) | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) | |
| Ayatollahi et al. | Effect of oral gabapentin on haemodynamic variables during microlaryngoscopic surgery | |
| Pistono et al. | What’s new about oral treatments in Multiple Sclerosis? Immunogenetics still under question |